ResMed (RMD) CEO Michael Farrell Receives 13,547-Share Award

What Happened Michael J. Farrell, Chairman, CEO and a director of ResMed Inc. (RMD), acquired 13,547 shares on August 14, 2026 as the result of a performance-based restricted stock unit award (transaction code A). The filing reports an acquisition price of $0 because these shares were earned/vested under a compensation award rather than bought on the open market.

Key Details

• Transaction date and type: 2026-08-14 — Award/Grant (A) of 13,547 shares; reported acquisition price $0.
• Filing date: Filed with the SEC on 2026-10-01 (the Form 4 was submitted after the transaction date).
• Shares owned after the transaction: Not specified in the filing.
• Footnote: These were performance-based RSUs originally granted on November 20, 2025; the compensation committee certified performance metrics were met on Aug 14, 2026. The stock units vest 1/3 each year on the anniversary of the grant.
• Timeliness: The Form 4 was filed late relative to the typical 2-business-day reporting requirement for insider transactions; late filings can be administrative oversights but may delay public disclosure.

Context This was a vesting/award event (not a market purchase or sale). Awards like earned RSUs reflect compensation outcomes tied to company performance metrics and do not necessarily indicate a buy/sell signal by the insider. There is no indication in this filing that the shares were immediately sold.